title: Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al.
authors: Roberta
authors: R
authors: Gualtierotti
authors: Francesca
authors: F
authors: Ingegnoli
authors: Pier Luigi
authors: PL
authors: Meroni
mesh_terms: D000069594:Abatacept; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018796:Immunoconjugates; D000069283:Rituximab; D000069594:Abatacept
references: Arthritis Res Ther. 2011 Feb 25;13(1):206
references: 21371350
references: Arthritis Rheum. 2009 Nov;60(11):3196-206
references: 19877045
references: Blood. 2011 Feb 3;117(5):1499-506
references: 21098742
references: Arthritis Res Ther. 2005;7(2):69-73
references: 15743492
references: Vaccine. 2003 Jul 28;21(24):3365-9
references: 12850341
references: Arthritis Rheum. 2006 Mar;54(3):899-907
references: 16508972
references: Clin Rheumatol. 2013 May;32(5):695-700
references: 23292481
references: Rheumatology (Oxford). 2011 Apr;50(4):806-8
references: 21177333